The world-wide obesity epidemic, predisposing towards several chronic diseases, not only poses a major public health issue, but also has a negative impact on individual' life expectancy and quality. These two dimensions may need distinct diagnostic and preventive approaches. Indeed, whether BMI and total adiposity are positively correlated with cardiometabolic disease risk at the population level, adipose tissue regional distribution and lipid storage in ectopic tissues define the obesity phenotype and, thus, better predict the risk of developing obesity complications at the individual level.Indeed, together with the more extensively studied intraabdominal adipose tissue, smaller ectopic visceral depots have, in the recent years, gained increasing attention for their putative role in mediating the local detrimental effects of obesity. It has also been increasingly appreciated that intracellular lipid accumulation in non-adipose tissues leads to pathological responses and impaired insulin signaling. This narrative review focuses on the phenotypic differences between different adipose depots that link their depotspecific biology to obesity specific complications.